 | • レポートコード：20QY06-03175 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、フェノフィブラートのグローバル市場について種類別（錠剤、カプセル）、用途別（病院、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・フェノフィブラート市場の概要 ・世界の主要地域別フェノフィブラート市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のフェノフィブラート市場規模2015-2026：種類別（錠剤、カプセル） ・世界のフェノフィブラート市場規模2015-2026：用途別（病院、ドラッグストア） ・フェノフィブラートの北米市場規模2015-2020 ・フェノフィブラートのヨーロッパ市場規模2015-2020 ・フェノフィブラートの中国市場規模2015-2020 ・フェノフィブラートの日本市場規模2015-2020 ・フェノフィブラートの東南アジア市場規模2015-2020 ・フェノフィブラートのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AbbVie、Lupin、Salix Pharmaceuticals、Vectura、Cipher Pharmaceuticals、Rhodes Pharmaceuticals、Impax Laboratories、Mylan、Teva、Sun Pharmaceutical、Bausch Health、HETERO、Aurobindo Pharma、Cipla、Amneal Pharmaceuticals、Prinston Pharmaceutical、Dr. Reddys Laboratories、APOTEX、Glenmark） ・フェノフィブラートの製造コスト分析 ・販売チャネル、流通業者、顧客 ・フェノフィブラートの市場動向・機会・課題 ・調査の結論 |
Fenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing triglyceride levels.
Market Analysis and Insights: Global Fenofibrate Market
The global Fenofibrate market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Fenofibrate Scope and Market Size
The global Fenofibrate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Fenofibrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Fenofibrate market is segmented into
Tablet
Capsule
Segment by Application, the Fenofibrate market is segmented into
Hospital
Drug store
The Fenofibrate market is analysed and market size information is provided by regions (countries). Segment by Application, the Fenofibrate market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Fenofibrate Market Share Analysis
Fenofibrate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Fenofibrate business, the date to enter into the Fenofibrate market, Fenofibrate product introduction, recent developments, etc.
The major vendors covered:
AbbVie
Lupin
Salix Pharmaceuticals
Vectura
Cipher Pharmaceuticals
Rhodes Pharmaceuticals
Impax Laboratories
Mylan
Teva
Sun Pharmaceutical
Bausch Health
HETERO
Aurobindo Pharma
Cipla
Amneal Pharmaceuticals
Prinston Pharmaceutical
Dr. Reddys Laboratories
APOTEX
Glenmark
Table of Contents
1 Fenofibrate Market Overview
1.1 Fenofibrate Product Scope
1.2 Fenofibrate Segment by Type
1.2.1 Global Fenofibrate Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Fenofibrate Segment by Application
1.3.1 Global Fenofibrate Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Drug store
1.4 Fenofibrate Market Estimates and Forecasts (2015-2026)
1.4.1 Global Fenofibrate Sales Growth Rate (2015-2026)
1.4.2 Global Fenofibrate Revenue and Growth Rate (2015-2026)
1.4.3 Global Fenofibrate Price Trends (2015-2026)
2 Fenofibrate Estimate and Forecast by Region
2.1 Global Fenofibrate Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Fenofibrate Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Fenofibrate Sales Market Share by Region (2015-2020)
2.2.2 Global Fenofibrate Revenue Market Share by Region (2015-2020)
2.3 Global Fenofibrate Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Fenofibrate Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Fenofibrate Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Fenofibrate Estimates and Projections (2015-2026)
2.4.2 Europe Fenofibrate Estimates and Projections (2015-2026)
2.4.3 China Fenofibrate Estimates and Projections (2015-2026)
2.4.4 Japan Fenofibrate Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Fenofibrate Estimates and Projections (2015-2026)
2.4.6 India Fenofibrate Estimates and Projections (2015-2026)
3 Global Fenofibrate Competition Landscape by Players
3.1 Global Top Fenofibrate Players by Sales (2015-2020)
3.2 Global Top Fenofibrate Players by Revenue (2015-2020)
3.3 Global Fenofibrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fenofibrate as of 2019)
3.4 Global Fenofibrate Average Price by Company (2015-2020)
3.5 Manufacturers Fenofibrate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Fenofibrate Players (Opinion Leaders)
4 Global Fenofibrate Market Size by Type
4.1 Global Fenofibrate Historic Market Review by Type (2015-2020)
4.1.1 Global Fenofibrate Sales Market Share by Type (2015-2020)
4.1.2 Global Fenofibrate Revenue Market Share by Type (2015-2020)
4.1.3 Global Fenofibrate Price by Type (2014-2020)
4.2 Global Fenofibrate Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Fenofibrate Sales Forecast by Type (2021-2026)
4.2.2 Global Fenofibrate Revenue Forecast by Type (2021-2026)
4.2.3 Global Fenofibrate Price Forecast by Type (2021-2026)
5 Global Fenofibrate Market Size by Application
5.1 Global Fenofibrate Historic Market Review by Application (2015-2020)
5.1.1 Global Fenofibrate Sales Market Share by Application (2015-2020)
5.1.2 Global Fenofibrate Revenue Market Share by Application (2015-2020)
5.1.3 Global Fenofibrate Price by Application (2015-2020)
5.2 Global Fenofibrate Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Fenofibrate Sales Forecast by Application (2021-2026)
5.2.2 Global Fenofibrate Revenue Forecast by Application (2021-2026)
5.2.3 Global Fenofibrate Price Forecast by Application (2021-2026)
3 North America Fenofibrate Market Facts & Figures
3.2 North America Fenofibrate Sales Market Share by Company (2015-2020)
3.3 North America Fenofibrate Sales Market Share by Type (2015-2020)
3.4 North America Fenofibrate Sales Market Share by Application (2015-2020)
4 Europe Fenofibrate Market Facts & Figures
4.2 Europe Fenofibrate Sales Market Share by Company (2015-2020)
4.3 Europe Fenofibrate Sales Market Share by Type (2015-2020)
4.4 Europe Fenofibrate Sales Market Share by Application (2015-2020)
5 China Fenofibrate Market Facts & Figures
5.2 China Fenofibrate Sales Market Share by Company (2015-2020)
5.3 China Fenofibrate Sales Market Share by Type (2015-2020)
5.4 China Fenofibrate Sales Market Share by Application (2015-2020)
6 Japan Fenofibrate Market Facts & Figures
6.2 Japan Fenofibrate Sales Market Share by Company (2015-2020)
6.3 Japan Fenofibrate Sales Market Share by Type (2015-2020)
6.4 Japan Fenofibrate Sales Market Share by Application (2015-2020)
7 Southeast Asia Fenofibrate Market Facts & Figures
7.2 Southeast Asia Fenofibrate Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Fenofibrate Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Fenofibrate Sales Market Share by Application (2015-2020)
8 India Fenofibrate Market Facts & Figures
8.2 India Fenofibrate Sales Market Share by Company (2015-2020)
8.3 India Fenofibrate Sales Market Share by Type (2015-2020)
8.4 India Fenofibrate Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Fenofibrate Business
12.1 AbbVie
12.1.1 AbbVie Fenofibrate Corporation Information
12.1.2 AbbVie Fenofibrate Business Overview and Total Revenue
12.1.3 AbbVie Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Fenofibrate Products Offered
12.1.5 AbbVie Recent Development
12.2 Lupin
12.2.1 Lupin Fenofibrate Corporation Information
12.2.2 Lupin Fenofibrate Business Overview and Total Revenue
12.2.3 Lupin Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Lupin Fenofibrate Products Offered
12.2.5 Lupin Recent Development
12.3 Salix Pharmaceuticals
12.3.1 Salix Pharmaceuticals Fenofibrate Corporation Information
12.3.2 Salix Pharmaceuticals Fenofibrate Business Overview and Total Revenue
12.3.3 Salix Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Salix Pharmaceuticals Fenofibrate Products Offered
12.3.5 Salix Pharmaceuticals Recent Development
12.4 Vectura
12.4.1 Vectura Fenofibrate Corporation Information
12.4.2 Vectura Fenofibrate Business Overview and Total Revenue
12.4.3 Vectura Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Vectura Fenofibrate Products Offered
12.4.5 Vectura Recent Development
12.5 Cipher Pharmaceuticals
12.5.1 Cipher Pharmaceuticals Fenofibrate Corporation Information
12.5.2 Cipher Pharmaceuticals Fenofibrate Business Overview and Total Revenue
12.5.3 Cipher Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Cipher Pharmaceuticals Fenofibrate Products Offered
12.5.5 Cipher Pharmaceuticals Recent Development
12.6 Rhodes Pharmaceuticals
12.6.1 Rhodes Pharmaceuticals Fenofibrate Corporation Information
12.6.2 Rhodes Pharmaceuticals Fenofibrate Business Overview and Total Revenue
12.6.3 Rhodes Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Rhodes Pharmaceuticals Fenofibrate Products Offered
12.6.5 Rhodes Pharmaceuticals Recent Development
12.7 Impax Laboratories
12.7.1 Impax Laboratories Fenofibrate Corporation Information
12.7.2 Impax Laboratories Fenofibrate Business Overview and Total Revenue
12.7.3 Impax Laboratories Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Impax Laboratories Fenofibrate Products Offered
12.7.5 Impax Laboratories Recent Development
12.8 Mylan
12.8.1 Mylan Fenofibrate Corporation Information
12.8.2 Mylan Fenofibrate Business Overview and Total Revenue
12.8.3 Mylan Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Mylan Fenofibrate Products Offered
12.8.5 Mylan Recent Development
12.9 Teva
12.9.1 Teva Fenofibrate Corporation Information
12.9.2 Teva Fenofibrate Business Overview and Total Revenue
12.9.3 Teva Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Teva Fenofibrate Products Offered
12.9.5 Teva Recent Development
12.10 Sun Pharmaceutical
12.10.1 Sun Pharmaceutical Fenofibrate Corporation Information
12.10.2 Sun Pharmaceutical Fenofibrate Business Overview and Total Revenue
12.10.3 Sun Pharmaceutical Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sun Pharmaceutical Fenofibrate Products Offered
12.10.5 Sun Pharmaceutical Recent Development
12.11 Bausch Health
12.11.1 Bausch Health Fenofibrate Corporation Information
12.11.2 Bausch Health Fenofibrate Business Overview and Total Revenue
12.11.3 Bausch Health Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bausch Health Fenofibrate Products Offered
12.11.5 Bausch Health Recent Development
12.12 HETERO
12.12.1 HETERO Fenofibrate Corporation Information
12.12.2 HETERO Fenofibrate Business Overview and Total Revenue
12.12.3 HETERO Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.12.4 HETERO Fenofibrate Products Offered
12.12.5 HETERO Recent Development
12.13 Aurobindo Pharma
12.13.1 Aurobindo Pharma Fenofibrate Corporation Information
12.13.2 Aurobindo Pharma Fenofibrate Business Overview and Total Revenue
12.13.3 Aurobindo Pharma Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Aurobindo Pharma Fenofibrate Products Offered
12.13.5 Aurobindo Pharma Recent Development
12.14 Cipla
12.14.1 Cipla Fenofibrate Corporation Information
12.14.2 Cipla Fenofibrate Business Overview and Total Revenue
12.14.3 Cipla Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Cipla Fenofibrate Products Offered
12.14.5 Cipla Recent Development
12.15 Amneal Pharmaceuticals
12.15.1 Amneal Pharmaceuticals Fenofibrate Corporation Information
12.15.2 Amneal Pharmaceuticals Fenofibrate Business Overview and Total Revenue
12.15.3 Amneal Pharmaceuticals Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Amneal Pharmaceuticals Fenofibrate Products Offered
12.15.5 Amneal Pharmaceuticals Recent Development
12.16 Prinston Pharmaceutical
12.16.1 Prinston Pharmaceutical Fenofibrate Corporation Information
12.16.2 Prinston Pharmaceutical Fenofibrate Business Overview and Total Revenue
12.16.3 Prinston Pharmaceutical Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Prinston Pharmaceutical Fenofibrate Products Offered
12.16.5 Prinston Pharmaceutical Recent Development
12.17 Dr. Reddys Laboratories
12.17.1 Dr. Reddys Laboratories Fenofibrate Corporation Information
12.17.2 Dr. Reddys Laboratories Fenofibrate Business Overview and Total Revenue
12.17.3 Dr. Reddys Laboratories Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Dr. Reddys Laboratories Fenofibrate Products Offered
12.17.5 Dr. Reddys Laboratories Recent Development
12.18 APOTEX
12.18.1 APOTEX Fenofibrate Corporation Information
12.18.2 APOTEX Fenofibrate Business Overview and Total Revenue
12.18.3 APOTEX Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.18.4 APOTEX Fenofibrate Products Offered
12.18.5 APOTEX Recent Development
12.19 Glenmark
12.19.1 Glenmark Fenofibrate Corporation Information
12.19.2 Glenmark Fenofibrate Business Overview and Total Revenue
12.19.3 Glenmark Fenofibrate Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Glenmark Fenofibrate Products Offered
12.19.5 Glenmark Recent Development
13 Fenofibrate Manufacturing Cost Analysis
13.1 Fenofibrate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Fenofibrate
13.4 Fenofibrate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Fenofibrate Distributors List
14.3 Fenofibrate Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Fenofibrate Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Fenofibrate Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Fenofibrate Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Fenofibrate Sales (K MT) by Region (2015-2020)
Table 5. Global Fenofibrate Sales Market Share by Region (2015-2020)
Table 6. Global Fenofibrate Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Fenofibrate Revenue Share by Region (2015-2020)
Table 8. Global Fenofibrate Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Fenofibrate Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Fenofibrate Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Fenofibrate Revenue Share Forecast by Region (2021-2026)
Table 12. Global Fenofibrate (K MT) of Key Companies (2015-2020)
Table 13. Global Fenofibrate Sales Share by Company (2015-2020)
Table 14. Global Fenofibrate Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Fenofibrate Revenue Share by Company (2015-2020)
Table 16. Global Fenofibrate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fenofibrate as of 2019)
Table 17. Global Fenofibrate Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Fenofibrate Manufacturing Sites and Area Served
Table 19. Manufacturers Fenofibrate Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Fenofibrate Players
Table 22. Global Fenofibrate Sales (K MT) by Type (2015-2020)
Table 23. Global Fenofibrate Sales Share by Type (2015-2020)
Table 24. Global Fenofibrate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Fenofibrate Price (K MT) by Type (2015-2020)
Table 26. Global Fenofibrate Sales Share by Type (2021-2026)
Table 27. Global Fenofibrate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Fenofibrate Revenue Share by Type (2021-2026)
Table 29. Global Fenofibrate Price (K MT) by Type (2021-2026)
Table 30. Global Fenofibrate Sales (K MT) by Application (2015-2020)
Table 31. Global Fenofibrate Sales Share by Application (2015-2020)
Table 32. Global Fenofibrate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Fenofibrate Price (K MT) by Application (2015-2020)
Table 34. Global Fenofibrate Sales (K MT) by Application (2021-2026)
Table 35. Global Fenofibrate Sales Share by Application (2021-2026)
Table 36. Global Fenofibrate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Fenofibrate Revenue Share by Application (2021-2026)
Table 38. Global Fenofibrate Price (K MT) by Application (2021-2026)
Table 39. United States Fenofibrate Sales (K MT) by Company (2015-2020)
Table 40. United States Fenofibrate Sales Market Share by Company (2015-2020)
Table 41. United States Fenofibrate Sales (K MT) by Type (2015-2020)
Table 42. United States Fenofibrate Sales Market Share by Type (2015-2020)
Table 43. United States Fenofibrate Sales (K MT) by Application (2015-2020)
Table 44. United States Fenofibrate Sales Market Share by Application (2015-2020)
Table 45. Europe Fenofibrate Sales (K MT) by Company (2015-2020)
Table 46. Europe Fenofibrate Sales Market Share by Company (2015-2020)
Table 47. Europe Fenofibrate Sales (K MT) by Type (2015-2020)
Table 48. Europe Fenofibrate Sales Market Share by Type (2015-2020)
Table 49. Europe Fenofibrate Sales (K MT) by Application (2015-2020)
Table 50. Europe Fenofibrate Sales Market Share by Type (2015-2020)
Table 51. China Fenofibrate Sales (K MT) by Company (2015-2020)
Table 52. China Fenofibrate Sales Market Share by Company (2015-2020)
Table 53. China Fenofibrate Sales (K MT) by Type (2015-2020)
Table 54. China Fenofibrate Sales Market Share by Type (2015-2020)
Table 55. China Fenofibrate Sales (K MT) by Application (2015-2020)
Table 56. China Fenofibrate Sales Market Share by Application (2015-2020)
Table 57. Japan Fenofibrate Sales (K MT) by Company (2015-2020)
Table 58. Japan Fenofibrate Sales Market Share by Company (2015-2020)
Table 59. Japan Fenofibrate Sales (K MT) by Type (2015-2020)
Table 60. Japan Fenofibrate Sales Market Share by Type (2015-2020)
Table 61. Japan Fenofibrate Sales (K MT) by Application (2015-2020)
Table 62. Japan Fenofibrate Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Fenofibrate Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Fenofibrate Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Fenofibrate Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Fenofibrate Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Fenofibrate Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Fenofibrate Sales Market Share by Application (2015-2020)
Table 69. India Fenofibrate Sales (K MT) by Company (2015-2020)
Table 70. India Fenofibrate Sales Market Share by Company (2015-2020)
Table 71. India Fenofibrate Sales (K MT) by Type (2015-2020)
Table 72. India Fenofibrate Sales Market Share by Type (2015-2020)
Table 73. India Fenofibrate Sales (K MT) by Application (2015-2020)
Table 74. India Fenofibrate Sales Market Share by Application (2015-2020)
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. AbbVie Fenofibrate Product
Table 79. AbbVie Recent Development
Table 80. Lupin Corporation Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Lupin Fenofibrate Product
Table 84. Lupin Recent Development
Table 85. Salix Pharmaceuticals Corporation Information
Table 86. Salix Pharmaceuticals Description and Business Overview
Table 87. Salix Pharmaceuticals Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Salix Pharmaceuticals Fenofibrate Product
Table 89. Salix Pharmaceuticals Recent Development
Table 90. Vectura Corporation Information
Table 91. Vectura Description and Business Overview
Table 92. Vectura Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Vectura Fenofibrate Product
Table 94. Vectura Recent Development
Table 95. Cipher Pharmaceuticals Corporation Information
Table 96. Cipher Pharmaceuticals Description and Business Overview
Table 97. Cipher Pharmaceuticals Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Cipher Pharmaceuticals Fenofibrate Product
Table 99. Cipher Pharmaceuticals Recent Development
Table 100. Rhodes Pharmaceuticals Corporation Information
Table 101. Rhodes Pharmaceuticals Description and Business Overview
Table 102. Rhodes Pharmaceuticals Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Rhodes Pharmaceuticals Fenofibrate Product
Table 104. Rhodes Pharmaceuticals Recent Development
Table 105. Impax Laboratories Corporation Information
Table 106. Impax Laboratories Description and Business Overview
Table 107. Impax Laboratories Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Impax Laboratories Fenofibrate Product
Table 109. Impax Laboratories Recent Development
Table 110. Mylan Corporation Information
Table 111. Mylan Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Mylan Description and Business Overview
Table 113. Mylan Fenofibrate Product
Table 114. Mylan Recent Development
Table 115. Teva Corporation Information
Table 116. Teva Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Teva Description and Business Overview
Table 118. Teva Fenofibrate Product
Table 119. Teva Recent Development
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Sun Pharmaceutical Fenofibrate Product
Table 124. Sun Pharmaceutical Recent Development
Table 125. Bausch Health Corporation Information
Table 126. Bausch Health Description and Business Overview
Table 127. Bausch Health Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Bausch Health Fenofibrate Product
Table 129. Bausch Health Recent Development
Table 130. HETERO Corporation Information
Table 131. HETERO Description and Business Overview
Table 132. HETERO Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. HETERO Fenofibrate Product
Table 134. HETERO Recent Development
Table 135. Aurobindo Pharma Corporation Information
Table 136. Aurobindo Pharma Description and Business Overview
Table 137. Aurobindo Pharma Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Aurobindo Pharma Fenofibrate Product
Table 139. Aurobindo Pharma Recent Development
Table 140. Cipla Corporation Information
Table 141. Cipla Description and Business Overview
Table 142. Cipla Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Cipla Fenofibrate Product
Table 144. Cipla Recent Development
Table 145. Amneal Pharmaceuticals Corporation Information
Table 146. Amneal Pharmaceuticals Description and Business Overview
Table 147. Amneal Pharmaceuticals Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Amneal Pharmaceuticals Fenofibrate Product
Table 149. Amneal Pharmaceuticals Recent Development
Table 150. Prinston Pharmaceutical Corporation Information
Table 151. Prinston Pharmaceutical Description and Business Overview
Table 152. Prinston Pharmaceutical Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Prinston Pharmaceutical Fenofibrate Product
Table 154. Prinston Pharmaceutical Recent Development
Table 155. Dr. Reddys Laboratories Corporation Information
Table 156. Dr. Reddys Laboratories Description and Business Overview
Table 157. Dr. Reddys Laboratories Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Dr. Reddys Laboratories Fenofibrate Product
Table 159. Dr. Reddys Laboratories Recent Development
Table 160. APOTEX Corporation Information
Table 161. APOTEX Description and Business Overview
Table 162. APOTEX Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. APOTEX Fenofibrate Product
Table 164. APOTEX Recent Development
Table 165. Glenmark Corporation Information
Table 166. Glenmark Description and Business Overview
Table 167. Glenmark Fenofibrate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Glenmark Fenofibrate Product
Table 169. Glenmark Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Fenofibrate Distributors List
Table 173. Fenofibrate Customers List
Table 174. Market Key Trends
Table 175. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 176. Key Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Fenofibrate Product Picture
Figure 2. Global Fenofibrate Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Fenofibrate Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Drug store Examples
Figure 8. Global Fenofibrate Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Fenofibrate Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Fenofibrate Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Fenofibrate Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Fenofibrate Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Fenofibrate Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Fenofibrate Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Fenofibrate Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Fenofibrate Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Fenofibrate Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Fenofibrate Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Fenofibrate Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Fenofibrate Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Fenofibrate Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Fenofibrate Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Fenofibrate Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Fenofibrate Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Fenofibrate Players Market Share by Revenue in Fenofibrate 2015 & 2019
Figure 26. Fenofibrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Fenofibrate Revenue Share by Type (2015-2020)
Figure 28. Global Fenofibrate Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Fenofibrate Revenue Share by Application (2015-2020)
Figure 30. Global Fenofibrate Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Fenofibrate Sales Market Share by Type in 2019
Figure 32. United States Fenofibrate Sales Market Share by Type in 2019
Figure 33. Europe Fenofibrate Sales Market Share by Company in 2019
Figure 34. Europe Fenofibrate Sales Market Share by Type in 2019
Figure 35. Europe Fenofibrate Sales Market Share by Application in 2019
Figure 36. China Fenofibrate Sales Market Share by Company in 2019
Figure 37. China Fenofibrate Sales Market Share by Type in 2019
Figure 38. China Fenofibrate Sales Market Share by Application in 2019
Figure 39. Japan Fenofibrate Sales Market Share by Company in 2019
Figure 40. Japan Fenofibrate Sales Market Share by Type in 2019
Figure 41. Japan Fenofibrate Sales Market Share by Application in 2019
Figure 42. Southeast Asia Fenofibrate Sales Market Share by Company in 2019
Figure 43. Southeast Asia Fenofibrate Sales Market Share by Type in 2019
Figure 44. Southeast Asia Fenofibrate Sales Market Share by Application in 2019
Figure 45. India Fenofibrate Sales Market Share by Company in 2019
Figure 46. India Fenofibrate Sales Market Share by Type in 2019
Figure 47. India Fenofibrate Sales Market Share by Application in 2019
Figure 48. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Vectura Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Cipher Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Rhodes Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Impax Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. HETERO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Prinston Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Dr. Reddys Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. APOTEX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Key Raw Materials Price Trend
Figure 68. Manufacturing Cost Structure of Fenofibrate
Figure 69. Manufacturing Process Analysis of Fenofibrate
Figure 70. Fenofibrate Industrial Chain Analysis
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 73. Porter's Five Forces Analysis
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…- モンテルカスト薬の世界市場レポート2020 Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Market Analysis and Insights: Global Montelukast Drug Market The global Montelukast Drug market was valued at US$ xx million in 2019 and will reach US$ …
- 口腔内崩壊錠の世界市場レポート2020 An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The …
- 象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…
- メチルフェニデート薬の世界市場レポート2020 Methylphenidate Drug is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Market Analysis and Insights: Global Methylphenidate Drug Market The global Methylphenidate Drug market was valued at US$ xx million in 2…